Powered Echelon Device in VATS Surgery

Inclusion Criteria: * Suspected or confirmed NSCLC (up to and including Stage II) * Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung * Performance status 0-1 (Eastern Cooperative Oncology Group classification) * ASA score \< 3 * No prior history of VATS or open lung surgery * Willing to give consent and comply with study-related evaluation and treatment schedule Exclusion Criteria: * Active bacterial infection or fungal infection; * Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure) * Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure * Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed) * Pregnancy * Physical or psychological condition which would impair study participation; * The patient is judged unsuitable for study participation by the Investigator for any other reason; or * Unable or unwilling to attend follow-up visits and examinations